Johnson & Johnson releases new data on Acuvue Oasys Max 1-Day for Astigmatism

Optometry Scotland has published a new report calling for the full integration of optical coherence tomography (OCT) in primary eyecare across Scotland.

✍ Some recent thoughts from my October Editor's Letter: It feels like dry eye care in Australia has entered a whole new realm in 2025. What was once a poorly understood condition, frustrating for both patients and clinicians, has become a hotbed of innovation, business opportunity, and clinical expertise. The turning point can be traced back to the landmark Tear Film & Ocular Surface Society (TFOS) DEWS II report in 2017, which provided legitimacy for the condition, and a framework for diagnosis and management. Since then, we’ve seen an explosion of dry eye products, technologies and, crucially, dedicated clinics. Now, with DEWS III released this year, practitioners have an even richer resource to guide evidence-based care. The momentum is clear in the 2025 Insight Dry Eye Directory – to be released this month. When it launched in 2021, the listings reflected a small but growing niche. This year, it has eclipsed all previous records, with almost 200 clinics across Australia listing their dry eye services – a milestone that underlines just how far the profession has come. The movement isn’t confined to independents either. EssilorLuxottica's OPSM now has more than 20 practices offering IPL and other advanced services, while Specsavers is executing one of the most ambitious dry eye rollouts the industry has seen. After piloting intense pulsed light (IPL) in select locations, the network is now adding low-level light therapy (LLLT) to create a combined offering, and is on track to reach 100 stores in 100 days in Australia. Liz Barrett's Dry Eye Solution is also proving the model’s scalability, expanding from its NSW base into Melbourne, and now even into London and Dublin. It’ll have 12 locations by the end of 2026. How she has made a living form standalone dry eye clinics is revealed in the link below, which also includes insights from Jennifer Rayner's Alleve Eye Clinic- Dry Eye Clinic Adelaide SA and Jason Holland's Oculuxe Clinic by The Eye Health Centre clinic. What’s driving this growth is the realisation that dry eye can be both life-changing for patients and commercially sustainable for practices if executed well. And perhaps it signals something larger: optometry’s trajectory towards becoming more clinically focused, with subspecialisation – or niche expertise – beginning to mirror the pathways long established in ophthalmology. https://lnkd.in/g7HiDyYQ

Specsavers has launched low-level light therapy (LLLT) alongside intense pulsed light (IPL) as part of a major rollout of advanced dry eye treatments that it hopes to have in 100 stores across Australia and New Zealand soon. Following a successful IPL pilot in a small number of stores, decision-makers within the network are convinced of the impact it can make on patients with dry eye and have given the greenlight to expand the service with a combined IPL and LLLT offering. Specsavers Optometry Australia Optometry Council of Australia and New Zealand (OCANZ) Optical Dispensers Australia Dry Eye Society

This is a significant development in the Australian #optometry landscape. Advanced dry eye care was once considered the domain of independents, but we are seeing more corporate networks figure out how to scale-up, and rollout what's considered a 'chair-heavy' condition.

𝗪𝗵𝗮𝘁 𝗪𝗲 𝗢𝗯𝘀𝗲𝗿𝘃𝗲𝗱 𝗶𝗻 𝗢𝗽𝘁𝗼𝗺𝗲𝘁𝗿𝘆 (𝗦𝗲𝗽𝘁 𝟮𝟵 – 𝗢𝗰𝘁 𝟯, 𝟮𝟬𝟮𝟱) Each week in optometry reminds us that innovation moves fast, and patient care is evolving even faster. From new therapies to tech-enabled solutions, it’s not just about what’s possible; it’s about how practices turn that progress into better outcomes and experiences for patients. 𝗞𝗲𝘆 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀 ✅ Patient QoL matters: New assessments for vision-degrading floaters highlight that understanding how eye conditions impact daily life is just as vital as clinical outcomes. ✅ Toric lens innovation: EyeCon 2025 showcased how new toric lenses help patients regain independence and confidence, closing gaps standard options can’t. ✅ Collaborative care counts: Integrated care between optometrists, ophthalmologists, and patients is improving results in areas like DME management and post-LASIK care. ✅ The horizon looks bold: Trials into post-LASIK night vision issues, glaucoma surgery, and nAMD therapies show a profession continually pushing boundaries. 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗻𝗴 𝗧𝗵𝗲 𝗗𝗼𝘁𝘀 Optometry isn’t just about lenses or procedures, it’s about conversations, choices, and trust. Staying aware of innovation ensures practices don’t just keep up, they lead in patient-centred care. At Verovian, we’ll keep sharing weekly insights to help practices turn knowledge into meaningful action, because the story of optometry is written in how care evolves, patient by patient. Stay tuned for more weekly insights. #OptometryUpdates #EyeCareInnovation #PatientExperience #VisionHealth #DryEye #ContactLenses #MyopiaManagement #OptometryPractice #VerovianCares

👁️ J&J Vision to Present New Data on ACUVUE® OASYS MAX 1-Day for Astigmatism at AAOpt Johnson & Johnson Vision is set to present new clinical data at the American Academy of Optometry's annual meeting, highlighting the performance of ACUVUE® OASYS MAX 1-Day for Astigmatism. The company will also spotlight ACUVUE® OASYS MAX 1-Day Multifocal for Astigmatism, the first and only daily disposable lens for patients with both presbyopia and astigmatism. 🔗 Read more here: https://lnkd.in/gne4yg6n #ContactLens #Presbyopia #NewProduct #EyeHealth #Congress #Optometry

Most of us have been watching the development of pharmacologic treatments for presbyopia with curiosity—and maybe a little skepticism. Kaleb Abbott, OD, MS, FAAO, FOWNS at Modern Optometry does a great job summarizing where things stand with the three current options. Each has a slightly different mechanism, onset, and target patient profile—and understanding those nuances is key to real-world success. As primary eye care doctors, our role is to evaluate not just if these drops work, but how and for whom. This review helps cut through the noise and clarify those distinctions. 👉 Read the full article here: https://lnkd.in/gGfaRwr3 LENZ Therapeutics QLOSI™ (pilocarpine HCL ophthalmic solution) 0.4% Amanda Johnston Kerry Robbers, NCLEC

𝗪𝗵𝗮𝘁 𝗪𝗲 𝗢𝗯𝘀𝗲𝗿𝘃𝗲𝗱 𝗶𝗻 𝗢𝗽𝘁𝗼𝗺𝗲𝘁𝗿𝘆 (𝗦𝗲𝗽𝘁 𝟵–𝟭𝟲, 𝟮𝟬𝟮𝟱) In optometry, it sometimes feels like innovation moves faster than we can catch our breath. New lenses, new treatments, new research, every week seems to bring another headline. But beneath the technology, a deeper question lingers: how do these changes shape the way practices care for people and build trust with their communities? 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗦𝗵𝗶𝗳𝘁𝘀 This week reminded us that patient needs are as diverse as ever. ✅ 𝗖𝗵𝗶𝗹𝗱𝗿𝗲𝗻’𝘀 𝗲𝘆𝗲𝘀𝗶𝗴𝗵𝘁 𝗶𝘀 𝗳𝗿𝗼𝗻𝘁 𝗼𝗳 𝗺𝗶𝗻𝗱. A new report confirmed what many providers already sense, myopia is on the rise, and proactive management is no longer optional but essential. Practices that act early can shape healthier lifetimes of vision. ✅ 𝗗𝗿𝘆 𝗲𝘆𝗲 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗱𝗲𝗺𝗮𝗻𝗱 𝗮𝘁𝘁𝗲𝗻𝘁𝗶𝗼𝗻. With treatments like Xiidra now available, we’re reminded that relief is not just clinical; it’s about improving daily comfort, confidence, and quality of life. ✅ 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝘁𝘆 𝗹𝗲𝗻𝘀𝗲𝘀 𝗯𝗿𝗶𝗻𝗴 𝗶𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝗰𝗲. Bausch + Lomb’s expanded GP portfolio offers new hope for patients with keratoconus, post-surgery complications, or prescriptions that don’t fit the “standard box.” Sometimes, the smallest adjustments can secure the deepest loyalty. ✅ 𝗖𝗮𝘁𝗮𝗿𝗮𝗰𝘁 𝗰𝗮𝗿𝗲 𝗴𝗼𝗲𝘀 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝘂𝗿𝗴𝗲𝗿𝘆. Premium IOLs promise freedom, but their real power lies in how well optometrists and ophthalmologists prepare patients for what’s possible, and what’s not. Communication, not technology, often determines satisfaction. ✅ 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝗼𝗻 𝘁𝗵𝗲 𝗵𝗼𝗿𝗶𝘇𝗼𝗻. A new trial is exploring treatment for post-LASIK night vision impairment, halos, glare, starbursts. It’s not here yet, but it signals that the future of vision care will keep pushing boundaries. 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗗𝗼𝘁𝘀 Living at the intersection of technology and patient care means optometry is never just about lenses or procedures. It’s about conversations, expectations, and the choices practices make to prioritize what matters most: helping people see and live better. At Verovian, we’ll be sharing these reflections more often. Because the real story of optometry isn’t just found in product launches or research papers, it’s in how each practice adapts, grows, and supports the people behind every pair of eyes. 𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝘄𝗲𝗲𝗸𝗹𝘆 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. #OptometryUpdates #EyeCareInnovation #MyopiaManagement #DryEyeCare #ContactLenses #PatientExperience #OptometryPractice #VerovianCares

EssilorLuxottica has most bases covered with myopia management in Australia and New Zealand. One of the industry’s most powerful lens-based interventions, backed with high quality monitoring tools like the REVO FC OCT and Myopia Expert 700, are compelling options for optometrists now offering the standard of care for this condition. But the company isn’t done there. It believes the solution lies not only in innovative products, but in collaboration – where optometrists, ophthalmologists, orthoptists, and vision scientists work in step to protect children’s eye health. Kate Gifford Carl James Sephora Miao Amy Pillay Optometry Australia Optical Dispensers Australia Myopia Profile The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Orthoptics Australia

Both visual acuity and visual image quality are reduced in those with Down syndrome, even while wearing optimized spectacle correction, according to a study in the journal Optometry & Vision Science. A sensory deficit in the visual system, in either the eye or retina or at the cortical level may be part of the reason along with uncorrected aberrations. Differences are seen in both retinal thickness and dendritic spines in patients with Down syndrome. Learn more: https://bit.ly/43a5hLJ #EyeCare #EyeHealth #ContactLenses